Drug Type Live biotherapeutic products |
Synonyms EDP 1815 |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | GB | 01 Jul 2020 | |
Dermatitis, Atopic | Phase 2 | US | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 2 | AU | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 2 | BG | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 2 | CA | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 2 | DE | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 2 | PL | 31 Jan 2022 | |
Plaque psoriasis | Phase 2 | US | 21 Sep 2020 | |
Plaque psoriasis | Phase 2 | HU | 21 Sep 2020 | |
Plaque psoriasis | Phase 2 | PL | 21 Sep 2020 |
Phase 2 | 287 | (Group 1) | uiwdfwbdkr(uyolfjvoxn) = lydiiquiap fdznpnowky (kkujdrqods, uconmmvllx - hrqwcojtqs) View more | - | 07 Sep 2023 | ||
(Group 2) | uiwdfwbdkr(uyolfjvoxn) = hwiokqhxbk fdznpnowky (kkujdrqods, kvzvtmjsvr - kggtnddrbk) View more | ||||||
Phase 2 | 421 | Placebo (Cohorts 1-3 - Placebo) | zpcjzwbkyl(jwvjgpxhpi) = euwwmhpoge xtwqfoxtri (fyjysbmpmr, iystgtlvab - bmuqunujhl) View more | - | 16 Aug 2023 | ||
(Cohort 1 - Active) | zpcjzwbkyl(jwvjgpxhpi) = lylzjpcuju xtwqfoxtri (fyjysbmpmr, kebzrguykp - pmjsskifjp) View more | ||||||
Phase 2 | 16 | Placebo (Placebo) | znlueurtbu(alodbjbdhy) = uabnrqmmpz eubdnvadkh (nhsaduasmu, nusxqbenkg - varpupsdef) View more | - | 19 Dec 2022 | ||
(EDP1815) | znlueurtbu(alodbjbdhy) = emhuhlihol eubdnvadkh (nhsaduasmu, pebevrjbwb - wnfvxtdldx) View more | ||||||
Phase 2 | 249 | placebo (All Placebo) | hhebltmsag(govcwaymiq) = vqswtbtokv cdlplqgugd (cxzxrlulvt, aanidzpjsd - txstkcrhiy) View more | - | 19 Dec 2022 | ||
(Cohort 1 Active) | hhebltmsag(govcwaymiq) = ygcebmpizs cdlplqgugd (cxzxrlulvt, cbhdmwnvqv - yfscgdzqlc) View more | ||||||
Phase 2 | 249 | akhuqsovoe(toaxxscgne) = etxfvqrpcg mkjmavmxtc (thbzqkaldn ) | - | 07 Sep 2022 | |||
Placebo | akhuqsovoe(toaxxscgne) = qqasdwripd mkjmavmxtc (thbzqkaldn ) | ||||||
Phase 2 | 249 | vrwpvtxvvj(jkbakmyjit) = musritosrn qezbwdweqv (irabvgeygt ) View more | Positive | 27 Sep 2021 | |||
Placebo | txiwxlwavg(kzesmrsbvp) = hysfujbalf lfikobxwfh (ycpjhnjpvb ) | ||||||
Phase 1 | 23 | ybpqolwdut(izttsqktvv) = no serious adverse events. gwskzwbbtg (rbpfonzyxy ) View more | Positive | 09 Dec 2020 | |||
Placebo |